Header Emsos

EMSOS studies published

2023 – Do’s and Don’ts in Primary Aneurysmal Bone Cysts of the Proximal Femur in Children and Adolescents: Retrospective Multicenter EPOS Study of 79 Patients.
van Geloven TPG, van der Heijden L, Laitinen MK, Campanacci DA, Döring K, Dammerer D, Badr IT, Haara M, Beltrami G, Kraus T, Scheider P, Soto-Montoya C, Umer M, Fiocco M, Coppa V, de Witte PB, van de Sande MAJ; EPOS Study Group.
J Pediatr Orthop. 2023 Jan 1;43(1): 37-45.

2021 – Cuomo P et al. Extra-abdominal desmoid tumor fibromatosis: a multicenter EMSOS study. BMC Cancer. 2021 Apr 20;21(1):437. doi: 10.1186/s12885-021-08189-6. PMID: 33879110; PMCID: PMC8059004.

2020 – Goedhart LM et al. Organization of Bone Sarcoma Care: A Cross-Sectional European Study. Orthop Surg. 2020;12(4):1030-1035. doi:10.1111/os.12716

2020 – Thaler M et al. Impact of the COVID-19 pandemic on patients suffering from musculoskeletal tumours. Int Orthop. 2020 Aug;44(8):1503-1509. doi: 10.1007/s00264-020-04636-4. Epub 2020 May 26. PMID: 32451657; PMCID: PMC7247966.

2020 – Staals EL et al. Expandable distal femur megaprosthesis: A European Musculoskeletal Oncology Society study on 299 cases. J Surg Oncol. 2020 Jun 7. doi: 10.1002/jso.26060. Epub ahead of print. PMID: 32506533.

2020 – Schutgens EM et al. Surgical Outcome and Oncological Survival of Osteofibrous Dysplasia-Like and Classic Adamantinomas: An International Multicenter Study of 318 Cases. J Bone Joint Surg Am. 2020 Oct 7;102(19):1703-1713. doi: 10.2106/JBJS.19.01056. PMID: 33027124; PMCID: PMC8569856.

2019 – Mastboom MJL et al. Surgical Treatment of Localized-Type Tenosynovial Giant Cell Tumors of Large Joints: A Study Based on a Multicenter-Pooled Database of 31 International Sarcoma Centers. J Bone Joint Surg Am. 2019 Jul 17;101(14):1309-1318. doi: 10.2106/JBJS.18.01147. Erratum in: J Bone Joint Surg Am. 2020 May 20;102(10):e49. PMID: 31318811.

2019 – Mastboom MJL et al. Surgical outcomes of patients with diffuse-type tenosynovial giant-cell tumours: an international, retrospective, cohort study. Lancet Oncol. 2019 Jun;20(6):877-886. doi: 10.1016/S1470-2045(19)30100-7. Epub 2019 Apr 24. PMID: 31029509.

2019 – Majoor BCJ et al. Prevalence and Clinical Features of Mazabraud Syndrome: A Multicenter European Study. J Bone Joint Surg Am. 2019 Jan 16;101(2):160-168. doi: 10.2106/JBJS.18.00062. PMID: 30653046.

2017 – Longhi A et al. Extraskeletal osteosarcoma: A European Musculoskeletal Oncology Society study on 266 patients. Eur J Cancer. 2017 Mar;74:9-16. doi: 10.1016/j.ejca.2016.12.016. Epub 2017 Feb 3. PMID: 28167373.

2015 – Frezza AM et al. Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. Eur J Cancer. 2015 Feb;51(3):374-81. doi: 10.1016/j.ejca.2014.11.007. Epub 2014 Dec 16. PMID: 25529371.

2015 – Verdegaal SH et al. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011;16(12):1771-9. doi: 10.1634/theoncologist.2011-0200. Epub 2011 Dec 6. PMID: 22147000; PMCID: PMC3248776.

2011 – Pansuriya TC et al. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet. 2011 Nov 6;43(12):1256-61. doi: 10.1038/ng.1004. PMID: 22057234; PMCID: PMC3427908.

2007 – Grimer RJ et al. Dedifferentiated chondrosarcoma: prognostic factors and outcome from a European group. Eur J Cancer. 2007 Sep;43(14):2060-5. doi: 10.1016/j.ejca.2007.06.016. Epub 2007 Aug 27. PMID: 17720491.

2005 – Grimer RJ et al. Periosteal osteosarcoma–a European review of outcome. Eur J Cancer. 2005 Dec;41(18):2806-11. doi: 10.1016/j.ejca.2005.04.052. Epub 2005 Nov 14. PMID: 16290134.

2003 – Grimer RJ et al. Osteosarcoma over the age of forty. Eur J Cancer. 2003 Jan;39(2):157-63. doi: 10.1016/s0959-8049(02)00478-1. PMID: 12509946.

1999 – Bielack SS et al. Malignant fibrous histiocytoma of bone: a retrospective EMSOS study of 125 cases. European Musculo-Skeletal Oncology Society. Acta Orthop Scand. 1999 Aug;70(4):353-60. doi: 10.3109/17453679908997824. PMID: 10569265.

AEC 5.4 - Sarcoma
Date: 18th - 19th April 2024
Location: Mercure, Sheffield
Programme Link

Information sheet
(PDF-File, Size: 262 KB)

Course On Muscusloskeletal Pathology 2024

Date: May 15th - 18th, 2024
Venue: Istituto Orthopedico Rizzoli
Bologna/ Italy
Website

EMSOS 2024

EMSOS 2024 website

EMSOS 2024 programme

Information sheet
(PDF-File, Size: 6,2 MB)